CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer
Ingrid Boere, Ignace Vergote, Rob Hanssen, Mathilde Jalving, Christine Gennigens, Petronella B. Ottevanger, Yes J van de Wouw, Cristianne J.F. Rijcken, Ron H.J. Mathijssen, Jonathan A. Ledermann
Topics & Concepts
MedicineDocetaxelOvarian cancerInternal medicineOncologyClinical endpointStage (stratigraphy)Progression-free survivalResponse Evaluation Criteria in Solid TumorsCancerPhases of clinical researchClinical trialChemotherapySurgeryBiologyPaleontologyOvarian cancer diagnosis and treatmentNanoparticle-Based Drug DeliveryIntraperitoneal and Appendiceal Malignancies